Ciprofloxacin 0.2 % / hydrocortisone 1 % Otic Suspension
RxNorm 309305
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 309305 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ciprofloxacin 0.2 % / hydrocortisone 1 % Otic Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Ciprofloxacin 2 mg/ML / hydrocortisone 10 mg/ML Otic Suspension
(Atom ID: 12340408)
PTPrescribable
Designated preferred name (PT):
Ciprofloxacin (as ciprofloxacin hydrochloride) 2 mg/mL and hydrocortisone 10 mg/mL ear suspension
(Atom ID: 12664861)
PSNPrescribable
Prescribable Name (PSN):
Ciprofloxacin 0.2 % / hydrocortisone 1 % Otic Suspension
(Atom ID: 6406645)
SYPrescribable
Synonym (SY):
Ciprofloxacin 0.2 % / hydrocortisone 1 % Otic Suspension
(Atom ID: 3271525)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 2 mg/1 mL and hydrocortisone 10 mg/1 mL conventional release ear suspension (clinical drug)
(Atom ID: 12665839)
Patient Education
Ciprofloxacin and Hydrocortisone Otic
Ciprofloxacin and hydrocortisone otic is used to treat outer ear infections in adults and children. Ciprofloxacin is in a class of medications called quinolone antibiotics. Hydrocortisone is in a class of medications called corticosteroids. The combination of ciprofloxacin and hydrocortisone works by killing the bacteria that cause infection and reducing swelling in the ear.
[Learn More]
* Please review the disclaimer below.